Catalyst
Description
  • Value proposition

    We find, fund and build transformational businesses via our unique partnership with the University of Oxford

    Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to find, fund and build transformational businesses across specialist areas of life sciences, health tech, AI, new compute, climate tech and agtech.

    Via our unique partnership with the University of Oxford, the world's #1 research university, we turn the world's most advanced science and technology into companies tackling the world's toughest challenges.

    In nine years, we have invested £0.7 billion in over 120 ambitious companies built on Oxford science. A key player in Oxford’s innovation ecosystem, we are highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. We are committed to doing this in an inclusive and sustainable way.

    Life Sciences, Deep Tech, and Health Tech

  • We found, fund and build for tomorrow’s challenges, today - Oxford Science Enterprises

    We found, fund and build for tomorrow’s challenges, today - Oxford Science Enterprises

  • https://www.oxfordscienceenterprises.com/
Entity interactions
Entity TypeTweets Articles
Intermediate Capital Group (ICG) Intermediate Capital Group (ICG)
Financial Services
Other

30 Apr 2024


8VC 8VC
Venture Capital and Private Equity Principals
Other

12 Jun 2024


Andera Partners Andera Partners
Venture Capital and Private Equity Principals
Other

30 Apr 2024


New Enterprise Associates (NEA) New Enterprise Associates (NEA)
Venture Capital and Private Equity Principals
Other

12 Jun 2024


F-Prime F-Prime
Venture Capital and Private Equity Principals
Other

12 Jun 2024


BioCity Nottingham BioCity Nottingham
Real Estate, proptech
Other

30 Apr 2024


Femtech Insider Femtech Insider
Software Development
Other

16 Jun 2024


Wealth Club Wealth Club
Financial Services
Other

30 Apr 2024


Par Equity Par Equity
Venture Capital and Private Equity Principals
Other

9 Jun 2024


Amber Therapeutics Amber Therapeutics
deeptech
Other

6 Mar 2025


Radars
Loading...